Today: 11 June 2026
Browse Category

Stock Market 17 October 2025 - 18 October 2025

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat shares plunged nearly 60% in one day, closing at $0.65 on Oct. 17 after a debt-for-equity swap triggered a flood of 316 million new shares. Founder and CEO Ethan Brown resigned from the board as analysts warned of a “death spiral.” The company reported Q2 revenue down 20% year-over-year and a net loss of $33 million. Cash reserves have dwindled to $117 million against $1.2 billion in debt.
18 October 2025
·
New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% in one day and 186% in two weeks after announcing progress on its 1-gigawatt AI data center in Texas. The company regained Nasdaq compliance, ended plans for share dilution, and rebranded from helium to AI infrastructure in August. NUAI remains pre-revenue, with $0.7 million in annual sales and steep losses. The stock is up 1300% from its 52-week low.
18 October 2025
····
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Soars 15% to 52-Week High on Psychedelic Breakthrough – What’s Next for MNMD?

MindMed (NASDAQ: MNMD) closed at $13.65 on Oct. 17, up 14.6% in one day and 68% year-to-date, after its LSD-based therapy MM120 showed strong Phase 2b results for Generalized Anxiety Disorder. The FDA granted Breakthrough Therapy status to MM120, with three Phase 3 trials underway. Needham & Co. initiated coverage with a Buy rating and $28 target. MindMed holds $237.9 million in cash, funding operations into 2027.
18 October 2025
··
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Gilead Sciences stock jumped over 4% on Oct. 17, 2025, closing at $122.81 and hitting a new 52-week high. The surge follows a patent settlement extending exclusivity for Biktarvy until 2036 and FDA approval of Yeztugo, a new HIV prevention shot. Gilead’s market cap stands near $150 billion after a 47% year-to-date gain. Analysts remain bullish but note concerns over U.S. drug pricing pressures.
18 October 2025
···
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy (LBRT) Stock Soars 28% on Earnings Surprise – Can the Rally Last?

Liberty Energy Inc. shares surged 28% to $15.32 Friday after quarterly earnings, despite revenue falling 17% year-over-year and an adjusted net loss of $0.06 per share. The company posted a GAAP profit of $43 million due to one-off gains and raised its dividend by 13%. The stock remains well below its early-2025 highs after a steep year-to-date decline. Oilfield activity slowed sharply in 2025, hitting Liberty’s core business.
18 October 2025
···
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Rani Therapeutics shares surged 248% to close at $1.64 on Oct. 17 after announcing a collaboration with Chugai Pharmaceutical worth up to $1.08 billion. The deal includes $10 million upfront and up to $175 million in milestones for the first drug. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. The company’s RaniPill technology delivers injectable drugs via oral capsules.
18 October 2025
···
AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

Tech companies including OpenAI, DeepMind, and Meta are spending over $325 billion by 2025 to develop artificial general intelligence, with leaders predicting AGI could arrive this decade. Some researchers warn superintelligent AI could escape human control and pose existential risks. Nvidia shares surged after a $100 billion investment in OpenAI, while Alphabet’s market value nears $3 trillion amid the AI boom.
18 October 2025
···
Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

The Nasdaq closed at 22,679.98 Friday, up 117 points, capping a volatile week near record highs. Nvidia shares retreated after hitting records, while AMD jumped 34% on an OpenAI chip deal. The KBW Regional Bank Index rebounded after sharp losses as banks addressed loan and fraud concerns. The VIX spiked to a six-month high before easing, with traders bracing for volatility ahead of major tech earnings and a delayed U.S. inflation report.
18 October 2025
·········
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 18.10.2025

Eaton Corporation received an 87% score under Validea’s Peter Lynch P/E/Growth strategy, passing key metrics for growth and valuation. Lululemon Athletica scored 79% in a Buffett-inspired analysis, meeting most fundamental criteria but missing on initial rate of return. Both are classified as large-cap growth stocks.
18 October 2025
·
Boeing’s Turbulent Week: Big Deal Greenlights, Strike Drama, and Hopes of a Comeback

Boeing’s Turbulent Week: Big Deal Greenlights, Strike Drama, and Hopes of a Comeback

The FAA cleared Boeing to raise 737 MAX production to 42 jets monthly, ending a two-year cap. The EU approved Boeing’s $4.7 billion Spirit AeroSystems takeover, requiring divestment of Airbus-linked assets. A 75-day strike in St. Louis delayed F-15EX fighter deliveries. Boeing stock rose 1.5% after the FAA decision; Q2 revenue hit $22.75 billion as losses narrowed.
18 October 2025
··
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed shares hit a 52-week high of $13.09 this week after its LSD-based drug MM120 showed strong Phase 2b results for generalized anxiety disorder and received FDA Breakthrough Therapy designation. The stock is up about 68% year-to-date. Analysts set average price targets near $27.83. MindMed holds $237.9 million in cash, funding operations into 2027.
18 October 2025
··
RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX shares closed at $157.80 on Oct. 17, up 0.5% as the S&P 500 fell. Pratt & Whitney’s new GTF Advantage engine won EASA certification, with commercial entry expected in 2026. Raytheon broke ground on a $53 million expansion to boost LTAMDS radar production amid rising global demand. RTX reports Q3 earnings Oct. 21, with analysts expecting $1.42 EPS on $21.5 billion revenue.
17 October 2025
···
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM Stock Hits Multi-Year High on AI & Quantum Hype – Can the Rally Last?

IBM shares traded near $276 on Oct. 16, up 28% year-to-date and close to all-time highs. Recent AI and quantum partnerships, along with strong Q2 results—$16.98 billion revenue and $2.80 EPS—have fueled the rally. Analysts remain cautious, with a consensus “Hold” rating and a $280 price target. Q3 earnings are due Oct. 22.
17 October 2025
····
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco Rides AI Wave as Stock Nears Year-High – What’s Next for CSCO?

Cisco shares traded near $69 on Oct. 17, 2025, close to their 52-week high of $72.55 and up about 30% from a year ago. The company beat earnings expectations with $0.99 EPS and $14.67 billion in revenue, driven by strong AI-related orders and new chip launches. Cisco raised its dividend to $0.41 per share. Wall Street’s consensus rates the stock a “Moderate Buy” with a $74–75 price target.
17 October 2025
···
Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Alibaba’s U.S. shares closed near $167 on Oct. 17 after rebounding from early losses, holding an 85% year-to-date gain and trading at four-year highs. The move followed a one-day 8% surge in September and outperformed a 4% drop in Hong Kong shares. Cloud revenue jumped 26% last quarter on AI demand, but heavy investment cut margins. Wall Street remains bullish, with most analysts rating BABA a “Buy.”
17 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health shares jumped 11% to $21.50 on Oct. 3, 2025, and traded near $21.76 on Oct. 14, up roughly 40% year-to-date. The company announced a $410 million convertible debt offering to fund AI initiatives and launched a new employer health plan with Hy-Vee. Q2 revenue rose to about $2.9 billion, but net losses widened to $228 million. Analysts remain bearish, with an average price target near $12.
17 October 2025
··
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit shares traded around $190 on Oct. 17, down 4.3% for the day and off sharply from a mid-September record near $283. The stock remains up about 244% year-to-date and over 600% since its March 2024 IPO. Q2 revenue jumped 78% to $500 million, with net income at $89 million. Analyst consensus rates the stock a “Moderate Buy,” with a 12-month price target averaging $202.
17 October 2025
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences shares rose to $123 on October 17, 2025, up nearly 40% from a year ago, lifting its market value to about $150 billion. The company settled U.S. patent litigation over HIV drug Biktarvy, blocking generics until 2036. Its new HIV prevention shot Yeztugo is seeing strong uptake, and Moody’s raised Gilead’s outlook to “Positive.” Gilead also announced a $1.5 billion cell therapy deal with Pregene.
17 October 2025
··
1 … 1,472 1,473 1,474 1,475 1,476 … 1,540

Stock Market Today

  • AMD Shares Drop 5% Amid Inflation Data and Geopolitical Tensions
    June 10, 2026, 9:14 PM EDT. AMD shares fell nearly 5% following a 4.2% U.S. inflation report, the highest since 2023, which boosted expectations for Federal Reserve rate hikes in December. Semiconductor stocks like AMD are highly sensitive to interest rate shifts as their valuations depend heavily on future earnings. Additional pressure came from the impending SpaceX IPO and geopolitical tensions after an Apache helicopter incident near the Strait of Hormuz, which heightened market risk aversion. Despite the sharp move, AMD remains volatile with 41 significant swings over the past year. The stock, though down from its 52-week high, has gained 103% year-to-date, rewarding long-term investors.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Go toTop